Immunoinformatic exploration of a multi-epitope-based peptide vaccine candidate targeting emerging variants of SARS-CoV-2

KM Kumar, Y Karthik, D Ramakrishna, S Balaji… - Frontiers in …, 2023 - frontiersin.org
Many countries around the world are facing severe challenges due to the recently emerging
variants of SARS-CoV-2. Over the last few months, scientists have been developing …

Exploring immunogenic CD8+ T-cell epitopes for peptide-based vaccine development against evolving SARS-CoV-2 variants: An immunoinformatics approach

MS Khan, M Shakya, CK Verma - VirusDisease, 2024 - Springer
The COVID-19 pandemic originated in Wuhan in 2019 due to a novel SARS-COV-2 (Severe
Acute Respiratory Syndrome Coronavirus 2) responsible for the massive number of deaths …

[HTML][HTML] Computational method for designing vaccines applied to virus-like particles (VLPs) as epitope carriers

P Prosper, RR Puertas, DMA Guérin, MM Branda - Vaccine, 2024 - Elsevier
Nonenveloped virus-like particles (VLPs) are self-assembled oligomeric structures
composed of one or more proteins that originate from diverse viruses. Because these VLPs …

Designing an immuno-epitope candidate vaccine from (Opa, ProA, ProB, RmpM and BamD) proteins against Neisseria gonorrhoeae and Neisseria meningitides

AA Dawood - Vacunas (English Edition), 2024 - Elsevier
The development of a conventional vaccine against gonococci has been difficult since there
are no precise correlates of immune protection and the mechanisms of protective immunity …

Prognosis of RNA, siRNA, Followed by the Immunological Response of the Proposed Vaccine (Vac534) against COVID-19

AA Dawood - Mikrobiolohichnyi Zhurnal, 2024 - ojs.microbiolj.org.ua
Despite the decline in Coronavirus infections, care must be taken to avoid new mutations
that allow the virus to escape vaccination and treatment. Viral RNA is responsible for virus …